You have entered the IISP: Interactive Information System on Pathogenomics
If you would like to insert information about your research or research group, please click to the following link to download the form. After filling it out, please send back to email@example.com or firstname.lastname@example.org.
Here you will find information about Research groups in the PathoGenoMics fields from the ERA-NET partner countries (Austria, Finland, France, Hungary, Israel, Latvia, Portugal, Slovenia and Spain).
This information is supposed to support cooperation between researchers from different European countries
and thus enhance the development of a European Research Area for PathoGenoMics .
The following information is available and can be searched for:
- researcher names
- Institution of the respective researcher, city and country of his/her institution
- Contact data of the researcher (address, phone, email)
- Research topics and studied microorganisms of the researcher
- Special techniques applied by the researcher
- Potential cooperation topics suggested by the researcher
If you have any comments/questions or if you would like to add some information, please contact email@example.com
|Name:||Dr. Kalscheuer, Rainer|
|Address:||Institute for Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf Universitätsstr. 1, 40225 Düsseldorf, Germany|
|Institution:||Institute for Medical Microbiology and Hospital Hygiene|
|Country:||Germany||Phone:||+49 (0)211 81 13027|
|Fax:||+49 (0)211 81 15906|
|My group is studying virulence mechanisms in Mycobacterium tuberculosis principally by applying comprehensive genetics working with virulent strains in a biosafety level 3 laboratory. The genetic manipulations include generation of gene deletions, generation of unmarked gene deletions, generation of conditional knock-outs, introduction of point mutations, transposon mutagenesis, heterologous gene expression and heterologous protein secretion. Research areas are: Analysis of essential genes, drug target discovery and validation Synthetic lethal parthways Transport processes Rational vaccine improvement by secretion of effector proteins|
|Special methods / technologies:|
|Biosafety level 3 laboratory; comprehensive genetic manipulations of slow-growing virulent mycobacteria: gene deletions, generation of unmarked gene deletions, conditional knock-outs, introduction of point mutations, transposon mutagenesis, heterologous gene expression, heterologous protein secretion|
|Suggestions for potential research cooperations:|